Rhenman & Partners Asset Management Ab Nektar Therapeutics Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $202,512 - $394,164	-63,884 Reduced 10.41%	550,000 $2.09 Million
Q1 2022 May 13, 2022	SELL	$4.16 - $13.72 $1.4 Million - $4.61 Million	-336,116 Reduced 35.38%	613,884 $3.31 Million
Q2 2021 Aug 13, 2021	SELL	$16.52 - $20.4 $5.9 Million - $7.29 Million	-357,196 Reduced 27.33%	950,000 $16.3 Million
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $708,834 - $1.09 Million	-42,804 Reduced 3.17%	1,307,196 $26.1 Million
Q4 2020 Jan 19, 2021	BUY	$15.77 - $19.03 $5.52 Million - $6.66 Million	350,000 Added 35.0%	1,350,000 $23 Million
Q3 2020 Oct 13, 2020	BUY	$16.59 - $24.79 $3.48 Million - $5.21 Million	210,000 Added 26.58%	1,000,000 $16.6 Million
Q2 2020 Jul 16, 2020	SELL	$16.86 - $23.44 $4.81 Million - $6.68 Million	-285,000 Reduced 26.51%	790,000 $18.3 Million
Q1 2020 Apr 16, 2020	SELL	$14.47 - $27.96 $361,750 - $699,000	-25,000 Reduced 2.27%	1,075,000 $19.2 Million
Q4 2019 Jan 17, 2020	SELL	$15.87 - $23.12 $1.59 Million - $2.31 Million	-100,000 Reduced 8.33%	1,100,000 $23.7 Million
Q3 2019 Oct 16, 2019	BUY	$16.91 - $36.27 $8.03 Million - $17.2 Million	475,000 Added 65.52%	1,200,000 $21.9 Million
Q2 2019 Jul 22, 2019	SELL	$31.0 - $36.3 $292,795 - $342,853	-9,445 Reduced 1.29%	725,000 $25.8 Million
Q1 2019 Apr 11, 2019	BUY	$31.58 - $46.35 $6.93 Million - $10.2 Million	219,445 Added 42.61%	734,445 $24.7 Million
Q4 2018 Feb 05, 2019	BUY	$30.43 - $56.65 $6.38 Million - $11.9 Million	209,607 Added 68.64%	515,000 $16.9 Million
Q3 2018 Oct 03, 2018	SELL	$46.46 - $68.49 $14.5 Million - $21.4 Million	-312,259 Reduced 50.56%	305,393 $18.6 Million
Q2 2018 Jul 20, 2018	BUY	$46.25 - $104.45 $19 Million - $42.8 Million	410,194 Added 197.72%	617,652 $30.2 Million
Q1 2018 Apr 11, 2018	SELL	$57.4 - $108.44 $8.38 Million - $15.8 Million	-146,045 Reduced 41.31%	207,458 $22 Million
Q4 2017 Jan 19, 2018	SELL	$23.02 - $60.5 $11.8 Million - $31 Million	-512,691 Reduced 59.19%	353,503 $21.1 Million
Q3 2017 Oct 13, 2017	BUY	$17.79 - $24.0 $15.4 Million - $20.8 Million	866,194	866,194 $20.8 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.8 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$12.2 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.74 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.56 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account